Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Randomised clinical trial: pemafibrate, a novel selective peroxisome proliferator-activated receptor modulator (SPPARM), versus placebo in patients with non-alcoholic fatty liver disease
Abstract This mini review explores the increasing prevalence of obesity in type 1 diabetes (T1D) and the challenges patients face in achieving optimal glycemic control with current treatments
Unlike heart disease or diabetes, fatty liver stays silent for decades
With any blood thinner (including alcohol, Vitamin E, pain relievers, and prescription blood thinners), a small bruise can turn into a much bigger bruise - and we know our patients want to avoid bruising from fillers
US$ 21.37
US$ 23.39
US$ 21.29
US$ 24.29
US$ 27.42
US$ 29.09
US$ 26.21
